|
US3324182A
(en)
|
1962-12-26 |
1967-06-06 |
Monsanto Res Corp |
Penta-alkyldialkylenetriamines
|
|
US3872171A
(en)
|
1971-05-24 |
1975-03-18 |
Pfizer |
Polyamines as antiviral agents in animals
|
|
US3799876A
(en)
|
1970-12-11 |
1974-03-26 |
Texaco Inc |
Corrosion inhibiting lubrication method
|
|
US4125544A
(en)
|
1977-06-09 |
1978-11-14 |
G. D. Searle |
20/22/23/24-Oxa-7-oxocholesterols and esters thereof
|
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
US4957735A
(en)
|
1984-06-12 |
1990-09-18 |
The University Of Tennessee Research Corporation |
Target-sensitive immunoliposomes- preparation and characterization
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
US4886499A
(en)
|
1986-12-18 |
1989-12-12 |
Hoffmann-La Roche Inc. |
Portable injection appliance
|
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
DE69034168T3
(de)
|
1989-03-21 |
2013-04-11 |
Vical, Inc. |
Expression von exogenen Polynukleotidsequenzen in Wirbeltieren
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
FR2676072B1
(fr)
|
1991-05-03 |
1994-11-18 |
Transgene Sa |
Vecteur de delivrance d'arn.
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
CA2128616A1
(en)
|
1992-01-23 |
1993-08-05 |
Gary H. Rhodes |
Ex vivo gene transfer
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
US5807861A
(en)
|
1994-03-24 |
1998-09-15 |
Cell Therapeutics, Inc. |
Amine substituted xanthinyl compounds
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US5730723A
(en)
|
1995-10-10 |
1998-03-24 |
Visionary Medical Products Corporation, Inc. |
Gas pressured needle-less injection device and method
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
GB9607549D0
(en)
|
1996-04-11 |
1996-06-12 |
Weston Medical Ltd |
Spring-powered dispensing device
|
|
US7288266B2
(en)
|
1996-08-19 |
2007-10-30 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
|
US6143276A
(en)
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
WO1999014346A2
(en)
|
1997-09-19 |
1999-03-25 |
Sequitur, Inc. |
SENSE mRNA THERAPY
|
|
US6673192B1
(en)
|
1997-09-25 |
2004-01-06 |
Loctite Corporation |
Multi-amine compound primers for bonding of polyolefins with cyanoacrylate adhesives
|
|
JP2001520889A
(ja)
|
1997-10-24 |
2001-11-06 |
バレンティス，インコーポレイティド |
ポリヌクレオチドトランスフェクション複合体を調製する方法
|
|
JP2001521759A
(ja)
|
1997-11-12 |
2001-11-13 |
ザ ブリガム アンド ウィメンズ ホスピタル，インコーポレイテッド |
ヒトアミロイド前駆体タンパク質遺伝子の翻訳エンハンサーエレメント
|
|
JP2001523480A
(ja)
|
1997-11-20 |
2001-11-27 |
バイカル インコーポレイテッド |
サイトカイン発現ポリヌクレオチドおよびそれらの組成物を用いた癌の処置
|
|
IT1298087B1
(it)
|
1998-01-08 |
1999-12-20 |
Fiderm S R L |
Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
|
|
US6432925B1
(en)
|
1998-04-16 |
2002-08-13 |
John Wayne Cancer Institute |
RNA cancer vaccine and methods for its use
|
|
GB9808268D0
(en)
|
1998-04-17 |
1998-06-17 |
Imp College Innovations Ltd |
Compound
|
|
US6395253B2
(en)
|
1998-04-23 |
2002-05-28 |
The Regents Of The University Of Michigan |
Microspheres containing condensed polyanionic bioactive agents and methods for their production
|
|
JP2000169864A
(ja)
|
1998-12-07 |
2000-06-20 |
New Japan Chem Co Ltd |
模型エンジン用燃料組成物
|
|
EP2286792A1
(en)
|
1999-02-26 |
2011-02-23 |
Novartis Vaccines and Diagnostics, Inc. |
Microemulsions with an adsorbent surface, comprising a microdroplet emulsion
|
|
WO2001023002A1
(en)
|
1999-09-30 |
2001-04-05 |
National Jewish Medical And Research Center |
Method for inhibition of pathogenic microorganisms
|
|
US7060291B1
(en)
|
1999-11-24 |
2006-06-13 |
Transave, Inc. |
Modular targeted liposomal delivery system
|
|
US7468275B2
(en)
|
2000-01-28 |
2008-12-23 |
The Scripps Research Institute |
Synthetic internal ribosome entry sites and methods of identifying same
|
|
WO2001055369A1
(en)
|
2000-01-28 |
2001-08-02 |
The Scripps Research Institute |
Synthetic internal ribosome entry sites and methods of identifying same
|
|
US20040142474A1
(en)
|
2000-09-14 |
2004-07-22 |
Expression Genetics, Inc. |
Novel cationic lipopolymer as a biocompatible gene delivery agent
|
|
US6696038B1
(en)
|
2000-09-14 |
2004-02-24 |
Expression Genetics, Inc. |
Cationic lipopolymer as biocompatible gene delivery agent
|
|
US7708915B2
(en)
|
2004-05-06 |
2010-05-04 |
Castor Trevor P |
Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
|
|
US6652886B2
(en)
|
2001-02-16 |
2003-11-25 |
Expression Genetics |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
|
|
DE10109897A1
(de)
|
2001-02-21 |
2002-11-07 |
Novosom Ag |
Fakultativ kationische Liposomen und Verwendung dieser
|
|
KR100904954B1
(ko)
|
2001-05-30 |
2009-06-26 |
더 스크립스 리서치 인스티튜트 |
핵산용 전달 시스템
|
|
ES2356934T3
(es)
|
2001-06-05 |
2011-04-14 |
Curevac Gmbh |
ARNm ESTABILIZADO CON UN CONTENIDO DE G/C AUMENTADO QUE CODIFICA PARA UN ANTÍGENO VIRAL.
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
DE10207178A1
(de)
|
2002-02-19 |
2003-09-04 |
Novosom Ag |
Komponenten für die Herstellung amphoterer Liposomen
|
|
US20050222064A1
(en)
|
2002-02-20 |
2005-10-06 |
Sirna Therapeutics, Inc. |
Polycationic compositions for cellular delivery of polynucleotides
|
|
EP1485070A1
(en)
|
2002-03-13 |
2004-12-15 |
Novartis AG |
Pharmaceutical microparticles
|
|
RU2302865C2
(ru)
|
2002-04-04 |
2007-07-20 |
Коли Фармасьютикал Гмбх |
Иммуностимулирующие g, u-содержащие олигорибонуклеотиды
|
|
EP1519714B1
(en)
|
2002-06-28 |
2010-10-20 |
Protiva Biotherapeutics Inc. |
Method and apparatus for producing liposomes
|
|
DE10229872A1
(de)
|
2002-07-03 |
2004-01-29 |
Curevac Gmbh |
Immunstimulation durch chemisch modifizierte RNA
|
|
DE10335833A1
(de)
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
US8668926B1
(en)
|
2003-09-15 |
2014-03-11 |
Shaker A. Mousa |
Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
|
|
CA2542099A1
(en)
|
2003-10-11 |
2005-04-21 |
Inex Pharmaceuticals Corporation |
Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
|
|
US7927873B2
(en)
|
2003-12-19 |
2011-04-19 |
University Of Cincinnati |
Polyamides for nucleic acid delivery
|
|
ATE537263T1
(de)
|
2004-06-07 |
2011-12-15 |
Protiva Biotherapeutics Inc |
Kationische lipide und verwendungsverfahren
|
|
WO2005121348A1
(en)
|
2004-06-07 |
2005-12-22 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering rna
|
|
MXPA06015234A
(es)
|
2004-06-30 |
2007-11-22 |
Nektar Therapeutics Al Corp |
Conjugados de fraccion polimero-factor ix.
|
|
DE102004042546A1
(de)
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
|
US8663599B1
(en)
|
2004-10-05 |
2014-03-04 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
|
EP1856179B1
(en)
|
2004-12-10 |
2013-05-15 |
Kala Pharmaceuticals, Inc. |
Functionalized poly (ether-anhydride) block copolymers
|
|
DE102005023170A1
(de)
|
2005-05-19 |
2006-11-23 |
Curevac Gmbh |
Optimierte Formulierung für mRNA
|
|
EP1912679A4
(en)
|
2005-06-15 |
2009-07-29 |
Massachusetts Inst Technology |
AMINOUS LIPIDS AND ITS USES
|
|
EP2479254A1
(en)
|
2005-08-24 |
2012-07-25 |
The Scripps Research Institute |
Translation enhancer-element dependent vector systems
|
|
DE102006007433A1
(de)
|
2006-02-17 |
2007-08-23 |
Curevac Gmbh |
Adjuvanz in Form einer Lipid-modifizierten Nukleinsäure
|
|
EP2012751A4
(en)
|
2006-03-21 |
2010-11-24 |
Morehouse School Of Medicine |
NEW NANOPARTICLES FOR THE DELIVERY OF ACTIVE AGENTS
|
|
ES2776100T3
(es)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
|
EP2019691B1
(en)
|
2006-05-15 |
2020-08-12 |
Massachusetts Institute of Technology |
Polymers for functional particles
|
|
US8728527B2
(en)
|
2006-07-24 |
2014-05-20 |
Luminus Biosciences, Inc. |
Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
|
|
CA2659301A1
(en)
|
2006-07-28 |
2008-02-07 |
Applera Corporation |
Dinucleotide mrna cap analogs
|
|
WO2008014979A2
(en)
|
2006-07-31 |
2008-02-07 |
Curevac Gmbh |
NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
|
|
CA2848238C
(en)
|
2006-10-03 |
2016-07-19 |
Tekmira Pharmaceuticals Corporation |
Lipid containing formulations
|
|
RU2492872C2
(ru)
|
2006-10-05 |
2013-09-20 |
Дзе Джонс Хопкинс Юниверсити |
Вододиспергируемые пероральные, парентеральные и местные композиции для плохо растворимых в воде лекарственных препаратов, включающие улучшающие их свойства полимерные наночастицы
|
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
|
DE102006061015A1
(de)
|
2006-12-22 |
2008-06-26 |
Curevac Gmbh |
Verfahren zur Reinigung von RNA im präparativen Maßstab mittels HPLC
|
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
|
US7943168B2
(en)
|
2007-03-05 |
2011-05-17 |
Washington University |
Nanoparticle delivery systems comprising a hydrophobic core and a lipid/surfactant layer comprising a membrane-lytic peptide
|
|
WO2008127688A1
(en)
|
2007-04-13 |
2008-10-23 |
Hart Communication Foundation |
Synchronizing timeslots in a wireless communication protocol
|
|
US8703204B2
(en)
|
2007-05-03 |
2014-04-22 |
Bend Research, Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
|
|
SI2494993T1
(sl)
|
2007-05-04 |
2019-01-31 |
Marina Biotech, Inc. |
Aminokislinski lipidi in njihove uporabe
|
|
US20090042825A1
(en)
|
2007-08-06 |
2009-02-12 |
Majed Matar |
Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer
|
|
US9144546B2
(en)
|
2007-08-06 |
2015-09-29 |
Clsn Laboratories, Inc. |
Nucleic acid-lipopolymer compositions
|
|
BRPI0815725A2
(pt)
|
2007-08-23 |
2015-02-10 |
Novartis Ag |
Métodos para detecção de oligonucleotídeos
|
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
|
ES2632052T3
(es)
|
2007-09-28 |
2017-09-08 |
Pfizer Inc. |
Direccionamiento a células de cáncer usando nanopartículas
|
|
CN101861165A
(zh)
|
2007-10-12 |
2010-10-13 |
麻省理工学院 |
疫苗纳米技术
|
|
TW200927915A
(en)
|
2007-10-25 |
2009-07-01 |
Croda Int Plc |
Laundry formulations and method of cleaning
|
|
EP2610340B1
(en)
|
2007-12-11 |
2014-10-01 |
The Scripps Research Institute |
Compositions and methods related to mRNA translational enhancer elements
|
|
US20110117125A1
(en)
|
2008-01-02 |
2011-05-19 |
Tekmira Pharmaceuticals Corporation |
Compositions and methods for the delivery of nucleic acids
|
|
ES2537703T3
(es)
|
2008-01-31 |
2015-06-11 |
Curevac Gmbh |
Ácidos nucleicos que comprenden la fórmula (NuGlXmGnNv)a y sus derivados como agentes/adyuvantes inmunoestimuladores
|
|
NZ588583A
(en)
|
2008-04-15 |
2012-08-31 |
Protiva Biotherapeutics Inc |
Novel lipid formulations for nucleic acid delivery
|
|
WO2009127230A1
(en)
|
2008-04-16 |
2009-10-22 |
Curevac Gmbh |
MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
|
|
WO2009129395A1
(en)
|
2008-04-16 |
2009-10-22 |
Abbott Laboratories |
Cationic lipids and uses thereof
|
|
WO2009129385A1
(en)
|
2008-04-16 |
2009-10-22 |
Abbott Laboratories |
Cationic lipids and uses thereof
|
|
MX2010011680A
(es)
|
2008-04-25 |
2011-05-03 |
Univ Northwestern |
Nanoestructuras adecuadas para secuestrar colesterol y otras moleculas.
|
|
US8697098B2
(en)
|
2011-02-25 |
2014-04-15 |
South Dakota State University |
Polymer conjugated protein micelles
|
|
PL215513B1
(pl)
|
2008-06-06 |
2013-12-31 |
Univ Warszawski |
Nowe boranofosforanowe analogi dinukleotydów, ich zastosowanie, czasteczka RNA, sposób otrzymywania RNA oraz sposób otrzymywania peptydów lub bialka
|
|
PL2285350T3
(pl)
|
2008-06-16 |
2018-03-30 |
Pfizer Inc. |
Sposoby otrzymywania funkcjonalizowanych kopolimerów dwublokowych stanowiących środki kierujące do stosowania przy wytwarzaniu nanocząstek terapeutycznych
|
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
|
KR20170127069A
(ko)
|
2008-06-16 |
2017-11-20 |
화이자 인코포레이티드 |
약물 부하된 중합체성 나노입자, 및 이의 제조 및 사용 방법
|
|
TW201019963A
(en)
|
2008-09-10 |
2010-06-01 |
Abbott Lab |
Polyethylene glycol lipid conjugates and uses thereof
|
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
|
ES2475065T3
(es)
|
2008-10-09 |
2014-07-10 |
Tekmira Pharmaceuticals Corporation |
Aminol�pidos mejorados y métodos para la administración de ácidos nucleicos
|
|
CN102245559B
(zh)
|
2008-11-07 |
2015-05-27 |
麻省理工学院 |
氨基醇类脂质和其用途
|
|
JP5747282B2
(ja)
|
2008-11-10 |
2015-07-15 |
テクミラ ファーマシューティカルズ コーポレイションＴｅｋｍｉｒａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏｒｐｏｒａｔｉｏｎ |
治療薬を送達するための新規な脂質及び組成物
|
|
WO2010057203A2
(en)
|
2008-11-17 |
2010-05-20 |
The Board Of Regents Of The University Of Texas System |
Hdl particles for delivery of nucleic acids
|
|
WO2010060818A1
(de)
|
2008-11-25 |
2010-06-03 |
Basf Se |
Alkoxylierte oligo- oder polyamine als oxidationsstabilisatoren
|
|
WO2010068866A2
(en)
|
2008-12-12 |
2010-06-17 |
Bind Biosciences |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
|
EA201100765A1
(ru)
|
2008-12-15 |
2012-04-30 |
Бинд Биосаиэнсис |
Наночастицы длительной циркуляции для замедленного высвобождения терапевтических средств
|
|
AU2010208035B2
(en)
|
2009-01-29 |
2016-06-23 |
Arbutus Biopharma Corporation |
Improved lipid formulation for the delivery of nucleic acids
|
|
WO2010088927A1
(en)
|
2009-02-09 |
2010-08-12 |
Curevac Gmbh |
Use of pei for the improvement of endosomal release and expression of transfected nucleic acids, complexed with cationic or polycationic compounds
|
|
US20140141089A1
(en)
|
2009-02-11 |
2014-05-22 |
Colorado School Of Mines |
Nanoparticles, Compositions Thereof, and Methods of Use, and Methods of Making the Same
|
|
JP5782602B2
(ja)
|
2009-03-20 |
2015-09-24 |
シーエルエスエヌ ラボラトリーズ、インコーポレイテッド |
ポリアミン誘導体
|
|
WO2010127159A2
(en)
|
2009-04-30 |
2010-11-04 |
Intezyne Technologies, Incorporated |
Polymeric micelles for polynucleotide encapsulation
|
|
US8715736B2
(en)
|
2009-04-30 |
2014-05-06 |
Florida Agricultural And Mechanical University |
Nanoparticle formulations for skin delivery
|
|
WO2010129687A1
(en)
|
2009-05-05 |
2010-11-11 |
Alnylam Pharmaceuticals, Inc |
Methods of delivering oligonucleotides to immune cells
|
|
CN102421417B
(zh)
|
2009-05-05 |
2016-03-02 |
阿尔尼拉姆医药品有限公司 |
脂质组合物
|
|
CN102985548B
(zh)
|
2009-05-16 |
2016-10-26 |
崔坤元 |
用于递送治疗分子的包含阳离子两亲物和辅脂质的组合物
|
|
NZ712719A
(en)
|
2009-06-10 |
2017-03-31 |
Arbutus Biopharma Corp |
Improved lipid formulation
|
|
JP5894913B2
(ja)
|
2009-06-15 |
2016-03-30 |
アルナイラム ファーマシューティカルズ， インコーポレイテッドＡｌｎｙｌａｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
Ｐｃｓｋ９遺伝子を標的とする、脂質で製剤化されたｄｓｒｎａ
|
|
CA2767127A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for delivery of therapeutic agents to solid tumors
|
|
US9018187B2
(en)
|
2009-07-01 |
2015-04-28 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
|
WO2011000106A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Improved cationic lipids and methods for the delivery of therapeutic agents
|
|
WO2011017548A1
(en)
|
2009-08-05 |
2011-02-10 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulated compositions and methods for inhibiting expression of eg5 and vegf genes
|
|
EP2281579A1
(en)
|
2009-08-05 |
2011-02-09 |
BioNTech AG |
Vaccine composition comprising 5'-Cap modified RNA
|
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
|
US8449916B1
(en)
|
2009-11-06 |
2013-05-28 |
Iowa State University Research Foundation, Inc. |
Antimicrobial compositions and methods
|
|
PH12012500929A1
(en)
|
2009-11-12 |
2012-11-26 |
Kao Corp |
Method for producing olefins
|
|
EP3403647A1
(en)
|
2009-12-01 |
2018-11-21 |
Translate Bio, Inc. |
Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
|
|
AU2010328336B2
(en)
|
2009-12-07 |
2017-03-02 |
Arbutus Biopharma Corporation |
Compositions for nucleic acid delivery
|
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
|
EA036522B1
(ru)
|
2009-12-11 |
2020-11-19 |
Пфайзер Инк. |
Фармацевтическая композиция, пригодная для лиофилизации, содержащая множество терапевтических частиц
|
|
NZ600725A
(en)
|
2009-12-18 |
2015-08-28 |
Univ British Colombia |
Methods and compositions for delivery of nucleic acids
|
|
AU2010334911A1
(en)
|
2009-12-23 |
2012-07-12 |
Novartis Ag |
Lipids, lipid compositions, and methods of using them
|
|
US9149432B2
(en)
|
2010-03-19 |
2015-10-06 |
Massachusetts Institute Of Technology |
Lipid vesicle compositions and methods of use
|
|
US8207290B2
(en)
|
2010-03-26 |
2012-06-26 |
Cerulean Pharma Inc. |
Methods and systems for generating nanoparticles
|
|
EP2558074B1
(en)
|
2010-04-08 |
2018-06-06 |
The Trustees of Princeton University |
Preparation of lipid nanoparticles
|
|
ES2745113T3
(es)
|
2010-04-09 |
2020-02-27 |
Pacira Pharmaceuticals Inc |
Método para formular liposomas multivesiculares
|
|
WO2011136368A1
(ja)
|
2010-04-28 |
2011-11-03 |
協和発酵キリン株式会社 |
カチオン性脂質
|
|
US20130156845A1
(en)
|
2010-04-29 |
2013-06-20 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulated single stranded rna
|
|
US9254327B2
(en)
|
2010-05-10 |
2016-02-09 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
|
US20130123338A1
(en)
|
2010-05-12 |
2013-05-16 |
Protiva Biotherapeutics, Inc. |
Novel cationic lipids and methods of use thereof
|
|
WO2011141704A1
(en)
|
2010-05-12 |
2011-11-17 |
Protiva Biotherapeutics, Inc |
Novel cyclic cationic lipids and methods of use
|
|
EP2387999A1
(en)
|
2010-05-21 |
2011-11-23 |
CureVac GmbH |
Histidine-containing solution for transfection and/or injection of nucleic acids and uses thereof
|
|
US8802863B2
(en)
|
2010-05-24 |
2014-08-12 |
Sirna Therapeutics, Inc. |
Amino alcohol cationic lipids for oligonucleotide delivery
|
|
US8748667B2
(en)
|
2010-06-04 |
2014-06-10 |
Sirna Therapeutics, Inc. |
Low molecular weight cationic lipids for oligonucleotide delivery
|
|
WO2012000104A1
(en)
|
2010-06-30 |
2012-01-05 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
|
JP5635690B2
(ja)
|
2010-07-01 |
2014-12-03 |
ポステック アカデミー‐インダストリー ファウンデーション |
細菌由来マイクロベシクルを用いた癌治療及び癌診断方法
|
|
US9192661B2
(en)
|
2010-07-06 |
2015-11-24 |
Novartis Ag |
Delivery of self-replicating RNA using biodegradable polymer particles
|
|
EP2590626B1
(en)
|
2010-07-06 |
2015-10-28 |
GlaxoSmithKline Biologicals SA |
Liposomes with lipids having an advantageous pka-value for rna delivery
|
|
CA2804494A1
(en)
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Virion-like delivery particles for self-replicating rna molecules
|
|
US20130230884A1
(en)
|
2010-07-16 |
2013-09-05 |
John Chaput |
Methods to Identify Synthetic and Natural RNA Elements that Enhance Protein Translation
|
|
US8968746B2
(en)
|
2010-07-30 |
2015-03-03 |
Curevac Gmbh |
Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
|
|
WO2012019630A1
(en)
|
2010-08-13 |
2012-02-16 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
|
|
WO2012024595A2
(en)
|
2010-08-20 |
2012-02-23 |
University Of Washington |
Circumferential aerosol device for delivering drugs to olfactory epithelium and brain
|
|
EP4066857B1
(en)
|
2010-08-31 |
2022-12-21 |
GlaxoSmithKline Biologicals SA |
Pegylated liposomes for delivery of immunogen-encoding rna
|
|
EP4008357B1
(en)
|
2010-08-31 |
2022-12-28 |
GlaxoSmithKline Biologicals SA |
Small liposomes for delivery of immunogen-encoding rna
|
|
CN103384515B
(zh)
|
2010-08-31 |
2017-02-15 |
诺华有限公司 |
适用于脂质体递送编码蛋白质的rna的脂质
|
|
US9549901B2
(en)
|
2010-09-03 |
2017-01-24 |
The Brigham And Women's Hospital, Inc. |
Lipid-polymer hybrid particles
|
|
US10307372B2
(en)
|
2010-09-10 |
2019-06-04 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
|
ES2987915T3
(es)
|
2010-09-20 |
2024-11-18 |
Sirna Therapeutics Inc |
Nuevos lípidos catiónicos de bajo peso molecular para el suministro de oligonucleótidos
|
|
JP2013540757A
(ja)
|
2010-09-24 |
2013-11-07 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
カプセル化された作用物質の放出を制御する能力を有するナノ構造ゲル
|
|
EP2621480B1
(en)
|
2010-09-30 |
2018-08-15 |
Sirna Therapeutics, Inc. |
Low molecular weight cationic lipids for oligonucleotide delivery
|
|
EP3485913A1
(en)
|
2010-10-21 |
2019-05-22 |
Sirna Therapeutics, Inc. |
Low molecular weight cationic lipids for oligonucleotide delivery
|
|
CN113214102A
(zh)
|
2010-11-15 |
2021-08-06 |
生命技术公司 |
含胺的转染试剂及其制备和使用方法
|
|
WO2012089225A1
(en)
|
2010-12-29 |
2012-07-05 |
Curevac Gmbh |
Combination of vaccination and inhibition of mhc class i restricted antigen presentation
|
|
CN102068701B
(zh)
|
2011-01-18 |
2012-11-07 |
沈阳药科大学 |
可断裂peg脂质衍生物在制剂中的应用
|
|
EP2667898A1
(en)
|
2011-01-26 |
2013-12-04 |
Cenix Bioscience GmbH |
Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes
|
|
US10363309B2
(en)
|
2011-02-04 |
2019-07-30 |
Case Western Reserve University |
Targeted nanoparticle conjugates
|
|
WO2012116715A1
(en)
|
2011-03-02 |
2012-09-07 |
Curevac Gmbh |
Vaccination in newborns and infants
|
|
CA2827118A1
(en)
|
2011-02-15 |
2012-08-23 |
Merrimack Pharmaceuticals, Inc. |
Compositions and methods for delivering nucleic acid to a cell
|
|
WO2012113413A1
(en)
|
2011-02-21 |
2012-08-30 |
Curevac Gmbh |
Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
|
|
WO2012116714A1
(en)
|
2011-03-02 |
2012-09-07 |
Curevac Gmbh |
Vaccination in elderly patients
|
|
CN102204920B
(zh)
|
2011-03-18 |
2013-03-20 |
海南本创医药科技有限公司 |
阿司匹林钠普伐他汀钠药物组合物固体制剂
|
|
EP2688590B1
(en)
|
2011-03-24 |
2020-02-12 |
GlaxoSmithKline Biologicals SA |
Adjuvant nanoemulsions with phospholipids
|
|
WO2012142132A1
(en)
|
2011-04-11 |
2012-10-18 |
Life Technologies Corporation |
Polymer particles and methods of making and using same
|
|
WO2013158127A1
(en)
|
2012-04-16 |
2013-10-24 |
Molecular Transfer, Inc. |
Agents for improved delivery of nucleic acids to eukaryotic cells
|
|
WO2012149376A2
(en)
|
2011-04-28 |
2012-11-01 |
Stc.Unm |
Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
|
|
EA201790030A1
(ru)
|
2011-04-29 |
2017-09-29 |
Селекта Байосайенсиз, Инк. |
Наноносители, вызывающие иммунную толерантность, для снижения ответной реакции цитотоксических т-лимфоцитов
|
|
AU2012254842A1
(en)
|
2011-05-12 |
2013-05-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Liposomes comprising polymer-conjugated lipids and related uses
|
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
|
WO2013052167A2
(en)
|
2011-06-02 |
2013-04-11 |
The Regents Of The University Of California |
Membrane encapsulated nanoparticles and method of use
|
|
ES2987057T3
(es)
|
2011-06-08 |
2024-11-13 |
Translate Bio Inc |
Lípidos escindibles
|
|
ES2740248T3
(es)
|
2011-06-08 |
2020-02-05 |
Translate Bio Inc |
Composiciones de nanopartículas lipídicas y métodos para la administración ARNm
|
|
CN102813929B
(zh)
|
2011-06-09 |
2014-04-09 |
沈阳药科大学 |
低浓度peg脂质衍生物及其应用
|
|
CA2840977A1
(en)
|
2011-07-06 |
2013-01-10 |
Novartis Ag |
Liposomes having useful n:p ratio for delivery of rna molecules
|
|
EP2729165B1
(en)
|
2011-07-06 |
2017-11-08 |
GlaxoSmithKline Biologicals SA |
Immunogenic combination compositions and uses thereof
|
|
CN103781470A
(zh)
|
2011-07-06 |
2014-05-07 |
诺华股份有限公司 |
包含核酸的水包油乳液
|
|
JP6120839B2
(ja)
|
2011-07-06 |
2017-04-26 |
ノバルティス アーゲー |
カチオン性水中油型エマルジョン
|
|
EP3508219A1
(en)
|
2011-07-06 |
2019-07-10 |
GlaxoSmithKline Biologicals S.A. |
Self-replicating rna prime - protein boost vaccines
|
|
WO2013016058A1
(en)
|
2011-07-22 |
2013-01-31 |
Merck Sharp & Dohme Corp. |
Novel bis-nitrogen containing cationic lipids for oligonucleotide delivery
|
|
JP2014525461A
(ja)
|
2011-08-31 |
2014-09-29 |
ノバルティス アーゲー |
免疫原をコードするｒｎａの送達のためのｐｅｇ化リポソーム
|
|
CN103930135A
(zh)
|
2011-08-31 |
2014-07-16 |
马林克罗特有限公司 |
使用h-膦酸酯的纳米颗粒peg修饰
|
|
US9126966B2
(en)
|
2011-08-31 |
2015-09-08 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use thereof
|
|
EP4245369A3
(en)
|
2011-09-08 |
2023-11-22 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
WO2013072929A2
(en)
|
2011-09-23 |
2013-05-23 |
Indian Institute Of Technology |
Nanop article based cosmetic composition
|
|
US9701623B2
(en)
|
2011-09-27 |
2017-07-11 |
Alnylam Pharmaceuticals, Inc. |
Di-aliphatic substituted pegylated lipids
|
|
CA2852064A1
(en)
|
2011-10-14 |
2013-04-18 |
Stc.Unm |
Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
|
|
CN103987847B
(zh)
|
2011-10-18 |
2017-06-16 |
迪克纳制药公司 |
胺阳离子脂质及其用途
|
|
WO2013057715A1
(en)
|
2011-10-20 |
2013-04-25 |
Novartis Ag |
Adjuvanted influenza b virus vaccines for pediatric priming
|
|
WO2013059922A1
(en)
|
2011-10-25 |
2013-05-02 |
The University Of British Columbia |
Limit size lipid nanoparticles and related methods
|
|
CN104023793B
(zh)
|
2011-10-31 |
2017-11-24 |
马林克罗特有限公司 |
用于治疗癌症的联合脂质体组合物
|
|
RS58562B1
(sr)
|
2011-11-04 |
2019-05-31 |
Nitto Denko Corp |
Postupak za sterilnu proizvodnju čestica lipid-nukleinska kiselina
|
|
US9579338B2
(en)
|
2011-11-04 |
2017-02-28 |
Nitto Denko Corporation |
Method of producing lipid nanoparticles for drug delivery
|
|
US9872870B2
(en)
|
2011-11-04 |
2018-01-23 |
University Of Notre Dame Du Lac |
Multifunctional micellar nanoparticle-based drug and targeting agent system
|
|
EP2776013B8
(en)
|
2011-11-08 |
2023-08-30 |
The Board of Trustees of the University of Arkansas |
Methods and compositions for x-ray induced release from ph sensitive liposomes
|
|
EP2785333A4
(en)
|
2011-12-02 |
2015-04-01 |
Pegasus Lab Inc |
AMPHIPATIVE COMPOSITIONS WITH DELAYED RELIEF ON LIPID BASIS
|
|
CA3165769A1
(en)
|
2011-12-07 |
2013-06-13 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
|
US20140308304A1
(en)
|
2011-12-07 |
2014-10-16 |
Alnylam Pharmaceuticals, Inc. |
Lipids for the delivery of active agents
|
|
EP2788316B1
(en)
|
2011-12-07 |
2019-04-24 |
Alnylam Pharmaceuticals, Inc. |
Branched alkyl and cycloalkyl terminated biodegradable lipids for the delivery of active agents
|
|
WO2013086526A1
(en)
|
2011-12-09 |
2013-06-13 |
The Regents Of The University Of California |
Liposomal drug encapsulation
|
|
AU2012353463B2
(en)
*
|
2011-12-12 |
2017-08-24 |
Kyowa Hakko Kirin Co., Ltd. |
Lipid nanoparticles containing combinations of cationic lipids
|
|
WO2013089151A1
(ja)
|
2011-12-12 |
2013-06-20 |
協和発酵キリン株式会社 |
カチオン性脂質を含有するドラッグデリバリーシステムのための脂質ナノ粒子
|
|
EP2604253A1
(en)
|
2011-12-13 |
2013-06-19 |
Otto Glatter |
Water-in-oil emulsions and methods for their preparation
|
|
US9636414B2
(en)
|
2011-12-15 |
2017-05-02 |
Biontech Ag |
Particles comprising single stranded RNA and double stranded RNA for immunomodulation
|
|
HRP20220717T1
(hr)
|
2011-12-16 |
2022-07-22 |
Modernatx, Inc. |
Modificirani pripravci mrna
|
|
WO2013103659A1
(en)
|
2012-01-04 |
2013-07-11 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus
|
|
EP2623121A1
(en)
|
2012-01-31 |
2013-08-07 |
Bayer Innovation GmbH |
Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen
|
|
WO2013113325A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Negatively charged nucleic acid comprising complexes for immunostimulation
|
|
WO2013113326A1
(en)
|
2012-01-31 |
2013-08-08 |
Curevac Gmbh |
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
|
|
EP2812360B1
(en)
|
2012-02-09 |
2022-08-31 |
Life Technologies Corporation |
Hydrophilic polymeric particles and methods for making same
|
|
WO2013120499A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly (a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
|
|
WO2013120498A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigen
|
|
WO2013120500A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
|
|
WO2013120497A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
|
HK1205751A1
(en)
|
2012-02-22 |
2015-12-24 |
Cerulean Pharma Inc. |
Conjugates, particles, compositions, and related methods
|
|
US20130243867A1
(en)
|
2012-02-23 |
2013-09-19 |
University Of South Florida (A Florida Non-Profit Corporation) |
Micelle compositions and methods for their use
|
|
SG11201405157PA
(en)
|
2012-02-24 |
2014-10-30 |
Protiva Biotherapeutics Inc |
Trialkyl cationic lipids and methods of use thereof
|
|
US10322089B2
(en)
|
2012-03-14 |
2019-06-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Nanoparticles, nanoparticle delivery methods, and systems of delivery
|
|
NO2825156T3
(OSRAM)
|
2012-03-16 |
2017-12-23 |
|
|
|
EP2830991A1
(en)
|
2012-03-26 |
2015-02-04 |
President and Fellows of Harvard College |
Lipid-coated nucleic acid nanostructures of defined shape
|
|
WO2013143555A1
(en)
|
2012-03-26 |
2013-10-03 |
Biontech Ag |
Rna formulation for immunotherapy
|
|
KR102186497B1
(ko)
|
2012-03-27 |
2020-12-04 |
큐어백 아게 |
인공 핵산 분자
|
|
KR20140139101A
(ko)
|
2012-03-27 |
2014-12-04 |
큐어백 게엠바하 |
5''top utr을 포함하는 인공 핵산 분자
|
|
SG10201710631RA
(en)
|
2012-03-27 |
2018-02-27 |
Curevac Ag |
Artificial nucleic acid molecules for improved protein or peptide expression
|
|
AU2013240051B2
(en)
|
2012-03-27 |
2017-11-30 |
Sirna Therapeutics, Inc. |
Diether based biodegradable cationic lipids for siRNA delivery
|
|
CA2868030C
(en)
|
2012-03-29 |
2021-05-25 |
Shire Human Genetic Therapies, Inc. |
Lipid-derived neutral nanoparticles
|
|
US20150064115A1
(en)
|
2012-04-05 |
2015-03-05 |
University Of Florida Research Foundation, Inc. |
Neurophilic nanoparticles
|
|
PL2836234T3
(pl)
|
2012-04-12 |
2020-02-28 |
Yale University |
Podłoża do kontrolowanego dostarczania różnych środków farmaceutycznych
|
|
WO2013158579A1
(en)
|
2012-04-19 |
2013-10-24 |
Merck Sharp & Dohme Corp. |
Novel diester and triester based low molecular weight, biodegradable cationic lipids for oligonucleotide delivery
|
|
WO2013163234A1
(en)
|
2012-04-23 |
2013-10-31 |
Massachusetts Institute Of Technology |
Stable layer-by-layer coated particles
|
|
HK1208377A1
(en)
|
2012-05-04 |
2016-03-04 |
The Johns Hopkins University |
Lipid-based drug carriers for rapid penetration through mucus linings
|
|
WO2013173693A1
(en)
|
2012-05-18 |
2013-11-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nanoparticles with enhanced entry into cancer cells
|
|
CN104582691A
(zh)
|
2012-05-23 |
2015-04-29 |
俄亥俄州立大学 |
脂膜白蛋白纳米颗粒组合物以及制备和使用其的方法
|
|
EP3498267A1
(en)
|
2012-05-25 |
2019-06-19 |
CureVac AG |
Reversible immobilization and/or controlled release of nucleic acid containing nanoparticles by (biodegradable) polymer coatings
|
|
CN104519915A
(zh)
|
2012-06-08 |
2015-04-15 |
夏尔人类遗传性治疗公司 |
肺部递送mRNA至非肺靶细胞
|
|
SI2858974T1
(sl)
|
2012-06-08 |
2019-01-31 |
Nitto Denko Corporation |
Lipidi za formulacije za dostavo terapevtskega sredstva
|
|
WO2014008334A1
(en)
|
2012-07-06 |
2014-01-09 |
Alnylam Pharmaceuticals, Inc. |
Stable non-aggregating nucleic acid lipid particle formulations
|
|
TW201408625A
(zh)
|
2012-07-06 |
2014-03-01 |
Kyowa Hakko Kirin Co Ltd |
陽離子性脂質
|
|
US9956291B2
(en)
|
2012-07-10 |
2018-05-01 |
Shaker A. Mousa |
Nanoformulation and methods of use of thyroid receptor beta1 agonists for liver targeting
|
|
WO2014028487A1
(en)
|
2012-08-13 |
2014-02-20 |
Massachusetts Institute Of Technology |
Amine-containing lipidoids and uses thereof
|
|
CA2881605A1
(en)
|
2012-08-14 |
2014-02-20 |
Aaron FROESE |
Internal structured self assembling liposomes
|
|
AU2013302526B2
(en)
|
2012-08-15 |
2018-03-22 |
The University Of Chicago |
Exosome-based therapeutics against neurodegenerative disorders
|
|
WO2014047649A1
(en)
|
2012-09-24 |
2014-03-27 |
The Regents Of The University Of California |
Methods for arranging and packing nucleic acids for unusual resistance to nucleases and targeted delivery for gene therapy
|
|
CA2925687A1
(en)
|
2012-09-27 |
2014-04-03 |
The University Of North Carolina At Chapel Hill |
Lipid coated nanoparticles containing agents having low aqueous and lipid solubilities and methods thereof
|
|
WO2014048969A1
(en)
|
2012-09-28 |
2014-04-03 |
Ionovation Gmbh |
Reactive, lipophilic nucleoside building blocks for the synthesis of hydrophobic nucleic acids
|
|
WO2014054026A1
(en)
|
2012-10-04 |
2014-04-10 |
University Of The Witwatersrand, Johannesburg |
Liposomal drug delivery system
|
|
WO2014071072A2
(en)
|
2012-11-02 |
2014-05-08 |
Pungente Michael D |
Novel cationic carotenoid-based lipids for cellular nucleic acid uptake
|
|
WO2014072997A1
(en)
|
2012-11-07 |
2014-05-15 |
Council Of Scientific & Industrial Research |
Nanocomplex containing amphipathic peptide useful for efficient transfection of biomolecules
|
|
WO2014089486A1
(en)
|
2012-12-07 |
2014-06-12 |
Shire Human Genetic Therapies, Inc. |
Lipidic nanoparticles for mrna delivering
|
|
SG10201710472PA
(en)
|
2013-02-22 |
2018-02-27 |
Curevac Ag |
Combination of vaccination and inhibition of the pd-1 pathway
|
|
US20160032316A1
(en)
|
2013-03-14 |
2016-02-04 |
The Trustees Of The University Of Pennsylvania |
Purification and Purity Assessment of RNA Molecules Synthesized with Modified Nucleosides
|
|
ES2795249T3
(es)
|
2013-03-15 |
2020-11-23 |
Translate Bio Inc |
Mejora sinérgica de la administración de ácidos nucleicos a través de formulaciones mezcladas
|
|
CN105143456A
(zh)
|
2013-03-15 |
2015-12-09 |
不列颠哥伦比亚大学 |
用于转染的脂质纳米粒子和相关方法
|
|
US10246708B2
(en)
|
2013-05-06 |
2019-04-02 |
Alnylam Pharmaceuticals, Inc. |
Dosages and methods for delivering lipid formulated nucleic acid molecules
|
|
US9895443B2
(en)
|
2013-06-26 |
2018-02-20 |
Massachusetts Institute Of Technology |
Multi-tailed lipids and uses thereof
|
|
WO2015002667A1
(en)
|
2013-07-01 |
2015-01-08 |
Myq, Inc. |
A location regulated point-of-sale system and enhancements
|
|
CA2919226C
(en)
|
2013-07-23 |
2024-05-14 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for delivering messenger rna
|
|
RU2733424C2
(ru)
|
2013-08-21 |
2020-10-01 |
Куревак Аг |
Способ повышения экспрессии кодируемых рнк белков
|
|
SG10201801433XA
(en)
|
2013-08-21 |
2018-04-27 |
Curevac Ag |
Composition and vaccine for treating prostate cancer
|
|
WO2015024666A1
(en)
|
2013-08-21 |
2015-02-26 |
Curevac Gmbh |
Composition and vaccine for treating lung cancer
|
|
CN105473158B
(zh)
|
2013-08-21 |
2021-04-13 |
库瑞瓦格股份公司 |
呼吸道合胞病毒(rsv)疫苗
|
|
CN105517569A
(zh)
|
2013-08-21 |
2016-04-20 |
库瑞瓦格股份公司 |
狂犬病疫苗
|
|
AU2014310935B2
(en)
|
2013-08-21 |
2019-11-21 |
CureVac SE |
Combination vaccine
|
|
WO2015062738A1
(en)
|
2013-11-01 |
2015-05-07 |
Curevac Gmbh |
Modified rna with decreased immunostimulatory properties
|
|
US9365610B2
(en)
|
2013-11-18 |
2016-06-14 |
Arcturus Therapeutics, Inc. |
Asymmetric ionizable cationic lipid for RNA delivery
|
|
ES2908827T3
(es)
|
2013-12-19 |
2022-05-04 |
Novartis Ag |
Lípidos y composiciones lipídicas para el suministro de agentes activos
|
|
WO2015101416A1
(en)
|
2013-12-30 |
2015-07-09 |
Curevac Gmbh |
Methods for rna analysis
|
|
JP6704850B2
(ja)
|
2013-12-30 |
2020-06-03 |
キュアバック アーゲー |
人工核酸分子
|
|
WO2015101415A1
(en)
|
2013-12-30 |
2015-07-09 |
Curevac Gmbh |
Artificial nucleic acid molecules
|
|
EP3110401A4
(en)
|
2014-02-25 |
2017-10-25 |
Merck Sharp & Dohme Corp. |
Lipid nanoparticle vaccine adjuvants and antigen delivery systems
|
|
US9833416B2
(en)
|
2014-04-04 |
2017-12-05 |
Ohio State Innovation Foundation |
Oligonucleotide lipid nanoparticle compositions, methods of making and methods of using the same
|
|
SI3766916T1
(sl)
|
2014-06-25 |
2023-01-31 |
Acuitas Therapeutics Inc. |
Formulacije novih lipidov in lipidnih nanodelcev za dostavo nukleinskih kislin
|
|
US9840479B2
(en)
|
2014-07-02 |
2017-12-12 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
|
CN114146063A
(zh)
|
2014-07-02 |
2022-03-08 |
川斯勒佰尔公司 |
信使rna的包封
|
|
CN104644555A
(zh)
|
2014-11-18 |
2015-05-27 |
中国科学院过程工程研究所 |
一种避免加速血液清除现象的长循环脂质体、制备方法及应用
|
|
EP3247328B1
(en)
|
2015-01-21 |
2026-01-07 |
Genevant Sciences Gmbh |
Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
|
|
EP3247363A4
(en)
|
2015-01-21 |
2018-10-03 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
|
WO2016176330A1
(en)
*
|
2015-04-27 |
2016-11-03 |
The Trustees Of The University Of Pennsylvania |
Nucleoside-modified rna for inducing an adaptive immune response
|
|
DK3313829T3
(da)
|
2015-06-29 |
2024-06-17 |
Acuitas Therapeutics Inc |
Lipider og lipide nanopartikelformuleringer til levering af nukleinsyrer
|
|
WO2017015630A2
(en)
|
2015-07-23 |
2017-01-26 |
Modernatx, Inc. |
Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereof
|
|
WO2017031232A1
(en)
|
2015-08-17 |
2017-02-23 |
Modernatx, Inc. |
Methods for preparing particles and related compositions
|
|
EP3350157B1
(en)
|
2015-09-17 |
2022-01-05 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
JP2018531290A
(ja)
|
2015-10-22 |
2018-10-25 |
モデルナティーエックス， インコーポレイテッド |
性感染症ワクチン
|
|
ES2922760T3
(es)
|
2015-10-22 |
2022-09-20 |
Modernatx Inc |
Vacunas de virus respiratorios
|
|
SI3368507T1
(sl)
|
2015-10-28 |
2023-04-28 |
Acuitas Therapeutics Inc. |
Novi lipidi in formulacije lipidnih nanodelcev za dostavo nukleinskih kislin
|
|
SI3386484T1
(sl)
*
|
2015-12-10 |
2022-06-30 |
Modernatx, Inc. |
Sestave in metode za dovajanje terapevtskih sredstev
|
|
WO2017100744A1
(en)
|
2015-12-11 |
2017-06-15 |
Preceres Inc. |
Aminolipidoids and uses thereof
|
|
JP7065036B2
(ja)
|
2015-12-17 |
2022-05-11 |
モダーナティエックス・インコーポレイテッド |
メチルマロニルＣｏＡムターゼをコードするポリヌクレオチド
|
|
ES2913626T5
(en)
|
2015-12-22 |
2025-05-12 |
Modernatx Inc |
Compounds and compositions for intracellular delivery of agents
|
|
WO2017117528A1
(en)
|
2015-12-30 |
2017-07-06 |
Acuitas Therapeutics, Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
EP3405579A1
(en)
|
2016-01-22 |
2018-11-28 |
Modernatx, Inc. |
Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereof
|
|
US10457631B2
(en)
|
2016-04-06 |
2019-10-29 |
Ohio State Innovation Foundation |
Biodegradable amino-ester nanomaterials for nucleic acid delivery
|
|
US20190167811A1
(en)
|
2016-04-13 |
2019-06-06 |
Modernatx, Inc. |
Lipid compositions and their uses for intratumoral polynucleotide delivery
|
|
WO2017192470A1
(en)
|
2016-05-03 |
2017-11-09 |
Merck Sharp & Dohme Corp. |
Combination therapy of anti-il-10 antibody and compositions comprising lipid nanoparticles and tlr9 agonist cpg oligonucleotides
|
|
CA3024509A1
(en)
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Mrna combination therapy for the treatment of cancer
|
|
CN115837014A
(zh)
|
2016-05-18 |
2023-03-24 |
摩登纳特斯有限公司 |
编码松弛素的多核苷酸
|
|
ES2973443T3
(es)
|
2016-05-18 |
2024-06-20 |
Modernatx Inc |
Polinucleótidos que codifican galactosa-1-fosfato uridililtransferasa para el tratamiento de galactosemia de tipo 1
|
|
EP3458107B1
(en)
|
2016-05-18 |
2024-03-13 |
ModernaTX, Inc. |
Polynucleotides encoding jagged1 for the treatment of alagille syndrome
|
|
JP7246930B2
(ja)
|
2016-05-18 |
2023-03-28 |
モデルナティエックス インコーポレイテッド |
インターロイキン－１２（ｉｌ１２）をコードするポリヌクレオチドおよびその使用
|
|
AU2017266932B2
(en)
|
2016-05-18 |
2023-04-20 |
Modernatx, Inc. |
Polynucleotides encoding alpha-galactosidase A for the treatment of Fabry disease
|
|
JP7210287B2
(ja)
|
2016-05-18 |
2023-01-23 |
モダーナティエックス・インコーポレイテッド |
Ｉｉ型シトルリン血症の治療のためのシトリンをコードするポリヌクレオチド
|
|
US20190382774A1
(en)
|
2016-05-18 |
2019-12-19 |
Modernatx, Inc. |
Polyribonucleotides containing reduced uracil content and uses thereof
|
|
AU2017266948B2
(en)
|
2016-05-18 |
2024-07-04 |
Fundacion Para La Investigacion Medica Aplicada |
Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyria
|
|
JP2019519601A
(ja)
*
|
2016-05-18 |
2019-07-11 |
モダーナティエックス・インコーポレイテッドＭｏｄｅｒｎａＴＸ， Ｉｎｃ． |
急性間欠性ポルフィリン症の治療のためのポルホビリノゲン脱アミノ酵素をコードするポリヌクレオチド
|
|
WO2017201325A1
(en)
*
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Combinations of mrnas encoding immune modulating polypeptides and uses thereof
|
|
WO2017201347A1
(en)
*
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
WO2017201333A1
(en)
*
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Polynucleotides encoding lipoprotein lipase for the treatment of hyperlipidemia
|
|
US20190298657A1
(en)
|
2016-05-18 |
2019-10-03 |
Modernatx, Inc. |
Polynucleotides Encoding Acyl-CoA Dehydrogenase, Very Long-Chain for the Treatment of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency
|
|
WO2017218704A1
(en)
|
2016-06-14 |
2017-12-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
EP3532103B1
(en)
|
2016-10-26 |
2025-12-03 |
Acuitas Therapeutics, Inc. |
Lipid nanoparticle formulations
|
|
MX2019004913A
(es)
|
2016-10-26 |
2019-09-16 |
Curevac Ag |
Vacunas de nanoparticulas lipidicas que comprenden acido ribonucleico mensajero (arnm).
|
|
US20190274968A1
(en)
|
2016-10-27 |
2019-09-12 |
The Trustees Of The University Of Pennsylvania |
Nucleoside-modified rna for inducing an adaptive immune response
|
|
EP3538067A1
(en)
|
2016-11-08 |
2019-09-18 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
KR20190110612A
(ko)
*
|
2017-02-01 |
2019-09-30 |
모더나티엑스, 인크. |
활성화 종양유전자 돌연변이 펩티드를 인코드하는 면역조절 치료 mrna 조성물
|
|
US11464848B2
(en)
|
2017-03-15 |
2022-10-11 |
Modernatx, Inc. |
Respiratory syncytial virus vaccine
|
|
PL3596041T3
(pl)
|
2017-03-15 |
2023-03-06 |
Modernatx, Inc. |
Związek i kompozycje do dokomórkowego dostarczania środków terapeutycznych
|
|
JP7220154B2
(ja)
|
2017-03-15 |
2023-02-09 |
モデルナティエックス インコーポレイテッド |
アミノ脂質の結晶形態
|
|
WO2018170270A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Varicella zoster virus (vzv) vaccine
|
|
EP3595727B1
(en)
|
2017-03-15 |
2024-11-27 |
ModernaTX, Inc. |
Lipid nanoparticle formulation
|
|
WO2018191719A1
(en)
|
2017-04-13 |
2018-10-18 |
Acuitas Therapeutics, Inc. |
Lipid delivery of therapeutic agents to adipose tissue
|
|
EP3615510B1
(en)
|
2017-04-28 |
2024-03-27 |
Acuitas Therapeutics, Inc. |
Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
WO2018225871A1
(ja)
|
2017-06-09 |
2018-12-13 |
協和発酵キリン株式会社 |
カチオン性脂質としての化合物
|
|
WO2018232120A1
(en)
|
2017-06-14 |
2018-12-20 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
US11639329B2
(en)
|
2017-08-16 |
2023-05-02 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
WO2019036030A1
(en)
|
2017-08-17 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS
|
|
CN111315359A
(zh)
|
2017-08-31 |
2020-06-19 |
摩登纳特斯有限公司 |
制备脂质纳米颗粒的方法
|
|
WO2019089828A1
(en)
|
2017-10-31 |
2019-05-09 |
Acuitas Therapeutics, Inc. |
Lamellar lipid nanoparticles
|
|
WO2019152557A1
(en)
|
2018-01-30 |
2019-08-08 |
Modernatx, Inc. |
Compositions and methods for delivery of agents to immune cells
|
|
EP3773702A2
(en)
|
2018-04-05 |
2021-02-17 |
CureVac AG |
Novel yellow fever nucleic acid molecules for vaccination
|
|
US20210170017A1
(en)
|
2018-04-17 |
2021-06-10 |
Curevac Ag |
Novel rsv rna molecules and compositions for vaccination
|
|
WO2020002525A1
(en)
|
2018-06-27 |
2020-01-02 |
Curevac Ag |
Novel lassa virus rna molecules and compositions for vaccination
|
|
CA3113436A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
CN113271926A
(zh)
|
2018-09-20 |
2021-08-17 |
摩登纳特斯有限公司 |
脂质纳米颗粒的制备及其施用方法
|
|
TW202039534A
(zh)
|
2018-12-14 |
2020-11-01 |
美商美國禮來大藥廠 |
KRAS變體mRNA分子
|
|
KR20220101077A
(ko)
|
2019-09-19 |
2022-07-19 |
모더나티엑스, 인크. |
치료제의 세포내 전달을 위한 분지형 꼬리 지질 화합물 및 조성물
|
|
CA3154720A1
(en)
|
2019-09-19 |
2021-03-25 |
Modernatx, Inc. |
Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
AU2020351220A1
(en)
|
2019-09-19 |
2022-04-07 |
Modernatx, Inc. |
Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
CN114206827B
(zh)
|
2020-04-09 |
2023-05-23 |
苏州艾博生物科技有限公司 |
脂质纳米颗粒组合物
|
|
CA3214481A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
AR127892A1
(es)
|
2021-12-10 |
2024-03-06 |
Modernatx Inc |
Compuestos y composiciones para la administración de agentes terapéuticos
|